Cite
Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?
MLA
Puetz, Katharina, et al. Neoadjuvant Chemoradiation for Patients with Advanced Oesophageal Cancer - Which Response Grading System Best Impacts Prognostic Discrimination? 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1201315673&authtype=sso&custid=ns315887.
APA
Puetz, K., Bollschweiler, E., Semrau, R., Moenig, S. P., Hoelscher, A. H., & Drebber, U. (2019). Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?
Chicago
Puetz, Katharina, Elfriede Bollschweiler, Robert Semrau, Stefan P. Moenig, Arnulf H. Hoelscher, and Uta Drebber. 2019. “Neoadjuvant Chemoradiation for Patients with Advanced Oesophageal Cancer - Which Response Grading System Best Impacts Prognostic Discrimination?” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1201315673&authtype=sso&custid=ns315887.